Pri-Med Care +

Clinical Trial Register

Clinical Trial Register

  • 2014-CURRENT TRIAL ID APD356-G000-401
  • 2013-CURRENT TRIAL ID NOVO NORDISK EX1250-4080
  • 2013-2014 PROTOCOL NUMBER TAK-875_303
  • 2013-2015 PROTOCOL: DAS181-2-04 SPONSOR NEXBIO
  • 2009-2011 TRIAL ID: PPF-GLP112754
  • 2006-2009 TRIAL ID: A3191172 TRIAL PHASE IV
  • 2006-2008 TRIAL ID: DAR-311 TRIAL PHASE IIIA
  • 2006-2008 TRIAL ID:NN1998-1683 TRIAL PHASE IIIA
  • 2006-2008 TRIAL ID:NN1998-1540 TRIAL PHASE IIIA
  • 2006-2008 TRIAL ID: BIASP-2191 SPONSOR NOVO NORDISK
  • 2007 TRIAL ID: GLP 110125 SPONSOR: GLAXOSMITHKLINE
  • 2003-2006 TRIAL ID: CDJN608B2302 SPONSOR NOVARTIS
2014-CURRENT TRIAL ID APD356-G000-401

A Study to Evaluate the Effect of Long-term Treatment with Drug X on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects.

2013-CURRENT TRIAL ID NOVO NORDISK EX1250-4080

A Trial Comparing Cardiovascular Safety of Insulin X Versus Insulin Y in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events.

2013-2014 PROTOCOL NUMBER TAK-875_303

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral DRUG X and 50 mg Compared to Placebo When Used in Combination with DRUG Yin Subjects with Type 2 Diabetes, with Protocol number TAK-875_303.

2013-2015 PROTOCOL: DAS181-2-04 SPONSOR NEXBIO

Phase 2B Study on Safety and Therapeutic Efficacy of DRUG-X in Adult Subjects With Naturally Acquired Influenza.

2009-2011 TRIAL ID: PPF-GLP112754

A Randomized Open Label ,Parallel Group Multicenter Study To Determine The Efficacy And Long Term Safety Of Drug X Compared With Insulin In Subjects With T2DM.

2006-2009 TRIAL ID: A3191172 TRIAL PHASE IV

A Randomized, Double Blind, Parallel Group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Drug X With Y And Z.

2006-2008 TRIAL ID: DAR-311 TRIAL PHASE IIIA

DORADO-Fixed doses of xxxxxx as compared to placebo in Resistant Hypertension .A phase 3 Randomized ,Double Blind ,Placebo –Controlled ,Muti-Center ,Parallel Group Study to Evaluate the Efficacy and Safety of Fixed Doses of xxxxx in Subjects with Resistant Systolic Hypertension Receiving Combination Therapy with four and more Antihypertensive Drugs,including Diuretic.

2006-2008 TRIAL ID:NN1998-1683 TRIAL PHASE IIIA

Inhaled Mealtime Insulin with the AERX IDMS Plus Drug P Versus DRUG P Alone In T2DM : A 26 Week ,Open Label Multicentered Randomized Parallel Trial To Investigate Safety And Efficacy.

2006-2008 TRIAL ID:NN1998-1540 TRIAL PHASE IIIA

Inhaled Mealtime Insulin with the AERX IDMS Plus Drug M Versus M & G versus R Plus M& G In T2DM : A 26 Week ,Open Label Multicentered Randomized Parallel Trial To Investigate Safety And Efficacy.

2006-2008 TRIAL ID: BIASP-2191 SPONSOR NOVO NORDISK

Comparison of Biphasic Insulin A Versus Insulin G in Subjects With Type 2 Diabetes.

2007 TRIAL ID: GLP 110125 SPONSOR: GLAXOSMITHKLINE

Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Drug -M Only.

2003-2006 TRIAL ID: CDJN608B2302 SPONSOR NOVARTIS

Long-term Study of N+V to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications.


Contact Us
footer-logo1

Board-certified Physicians and certified skilled staff with in-house diagnostic tools, makes Pri-Med Care+ a one-stop clinic your family.

Location

location